ATE344454T1 - Oxydativer stoffwechsel in glatten muskelzellen: verfahren in beziehung dazu - Google Patents

Oxydativer stoffwechsel in glatten muskelzellen: verfahren in beziehung dazu

Info

Publication number
ATE344454T1
ATE344454T1 AT97919499T AT97919499T ATE344454T1 AT E344454 T1 ATE344454 T1 AT E344454T1 AT 97919499 T AT97919499 T AT 97919499T AT 97919499 T AT97919499 T AT 97919499T AT E344454 T1 ATE344454 T1 AT E344454T1
Authority
AT
Austria
Prior art keywords
oxidative metabolism
smooth muscle
muscle cells
metabolism
increase
Prior art date
Application number
AT97919499T
Other languages
English (en)
Inventor
Joseph Floyd Clark
Thomas Andrew Da Cadoux-Hudson
Original Assignee
Medical Res Council
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9608046.0A external-priority patent/GB9608046D0/en
Priority claimed from GBGB9610915.2A external-priority patent/GB9610915D0/en
Priority claimed from GBGB9702509.2A external-priority patent/GB9702509D0/en
Application filed by Medical Res Council filed Critical Medical Res Council
Application granted granted Critical
Publication of ATE344454T1 publication Critical patent/ATE344454T1/de

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5082Supracellular entities, e.g. tissue, organisms
    • G01N33/5088Supracellular entities, e.g. tissue, organisms of vertebrates
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/973Simultaneous determination of more than one analyte
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/811Test for named disease, body condition or organ function
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/815Test for named compound or class of compounds
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/826Additives, e.g. buffers, diluents, preservatives
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/904Oxidation - reduction indicators
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/10Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/107497Preparation composition [e.g., lysing or precipitation, etc.]
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/25Chemistry: analytical and immunological testing including sample preparation
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/25Chemistry: analytical and immunological testing including sample preparation
    • Y10T436/25125Digestion or removing interfering materials
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/25Chemistry: analytical and immunological testing including sample preparation
    • Y10T436/2525Stabilizing or preserving

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Toxicology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT97919499T 1996-04-18 1997-04-18 Oxydativer stoffwechsel in glatten muskelzellen: verfahren in beziehung dazu ATE344454T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9608046.0A GB9608046D0 (en) 1996-04-18 1996-04-18 Smooth muscle constrictions and spasms: methods and materials relating thereto
GBGB9610915.2A GB9610915D0 (en) 1996-05-24 1996-05-24 Smoooth muscle constrictions and spasms methods and materials relating thereto
GBGB9702509.2A GB9702509D0 (en) 1997-02-07 1997-02-07 Smooth muscle constrictions and spasms:methods and materials relating thereto

Publications (1)

Publication Number Publication Date
ATE344454T1 true ATE344454T1 (de) 2006-11-15

Family

ID=27268251

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97919499T ATE344454T1 (de) 1996-04-18 1997-04-18 Oxydativer stoffwechsel in glatten muskelzellen: verfahren in beziehung dazu

Country Status (8)

Country Link
US (2) US6080385A (de)
EP (1) EP0898707B1 (de)
JP (1) JP3759620B2 (de)
AT (1) ATE344454T1 (de)
AU (1) AU2394597A (de)
DE (1) DE69736893T2 (de)
ES (1) ES2276423T3 (de)
WO (1) WO1997039353A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0003225D0 (en) * 2000-02-11 2000-04-05 Medical Res Council Models, methods and materials relating to clinical conditions associated with reactive oxygen species
GB0004549D0 (en) 2000-02-25 2000-04-19 Isis Innovation Degradation fragments
JP2004502944A (ja) * 2000-07-07 2004-01-29 パナシア ファーマシューティカルズ インコーポレーテッド 嗅覚ニューロン培養物ならびにその製造および使用方法
US20040157280A1 (en) * 2001-09-17 2004-08-12 Paul Wentworth Antibody mediated ozone generation
US20050129680A1 (en) * 2001-09-17 2005-06-16 Paul Wentworth Antimicrobial activity of antibodies
US20040116350A1 (en) * 2001-09-17 2004-06-17 Paul Wentworth Jr Methods and compositions relating to hydrogen peroxide and superoxide production by antibodies
AU2003288058A1 (en) * 2002-11-14 2004-06-03 Novartis Ag Antibody- or neutrophil-mediated ozone generation
RU2241378C2 (ru) * 2002-12-30 2004-12-10 Научно-исследовательский институт общей реаниматологии РАМН Способ определения степени утилизации кислорода тканями организма

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4445500A (en) * 1982-03-03 1984-05-01 Thomas Jefferson University Stroke treatment utilizing extravascular circulation of oxygenated synthetic nutrients to treat tissue hypoxic and ischemic disorders

Also Published As

Publication number Publication date
DE69736893D1 (de) 2006-12-14
EP0898707A1 (de) 1999-03-03
EP0898707B1 (de) 2006-11-02
DE69736893T2 (de) 2007-09-06
JP2000513806A (ja) 2000-10-17
AU2394597A (en) 1997-11-07
JP3759620B2 (ja) 2006-03-29
US6080385A (en) 2000-06-27
US6284542B1 (en) 2001-09-04
WO1997039353A1 (en) 1997-10-23
ES2276423T3 (es) 2007-06-16

Similar Documents

Publication Publication Date Title
Kimber et al. Development of a murine local lymph node assay for the determination of sensitizing potential
DE3476455D1 (en) Polymer catalyst transducers and use thereof in test kits for analytical methods
Kaatsch et al. An extended study on childhood malignancies in the vicinity of German nuclear power plants
DE59004587D1 (de) Messzelle für den elektrochemischen Gasnachweis.
GB2348702A (en) Antibiotic sensitivity testing
MX9707889A (es) Metodo y dispositivo para diagnosticar y distinguir dolor de pecho en inicio temprano del mismo.
DK1067384T3 (da) Prøvedetektion for at igangsætte tidsmålingen i en elektrokemisk test
ATE279531T1 (de) Test zum nachweis der aktivität von phospho-n- acetylmuramyl-pentapeptid-translokase
DE59914830D1 (de) Verfahren und testbesteck zur beurteilung der oxid messung ihrer antiradikalen aktivität
ATE344454T1 (de) Oxydativer stoffwechsel in glatten muskelzellen: verfahren in beziehung dazu
ATE408829T1 (de) Verfahren und assaykits zum nachweis mononuklearer zellphänotypen
Muniz et al. Ntp pyrophosphohydrolase in human chondrocalcinotic and osteoarthritic cartilage: some biochemical characteristic
CZ228898A3 (cs) Způsob určení stavu jaterních funkcí jedince, včetně u příjemce jaterního štěpu
ATE155689T1 (de) Aktivätsmessungen des amylin
Zheng et al. Assessment of human DNA repair (NER) capacity with DNA repair rate (DRR) by comet assay
Oaklander et al. Early changes in degenerating mouse sciatic nerve are associated with endothelial cells
ATE365921T1 (de) Immunologische zusammensetzung zum nachweis von blasenkrebs und verfahren zu ihrer verwendung
Alarcon et al. One-carbon metabolism disturbances in affective disorders: A preliminary report
ES2090492T3 (es) Determinacion de analitos de peso molecular elevado.
ATE229185T1 (de) Verfahren zur krebsdetektion
CA2404502A1 (en) Diagnosis of autoimmune disease by detecting thyroid stimulating autoantibodies
Forget et al. Diamine oxidase in serum and small intestinal biopsy tissue in childhood celiac disease
FI990380A0 (fi) Diagnostinen ja seulontamenetelmä
AU586235B2 (en) Assay for salicylate and apparatus for performing same
EP1173764B1 (de) Verfahren zur abschätzung des individuellen risikos einer irreversiblen nervenschädigung, das schritte zur quantitativen bestimmung der pepsinogen-i (pgi) und vitamin b12 konzentrationen umfasst

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties